Evidence map›Paper›PMID 29740917›Full record

ReviewAngewandte Chemie (International ed. in English)2018

Emerging Methods and Design Principles for Cell-Penetrant Peptides.

Leila Peraro, Joshua A Kritzer

Abstract readReview
In one paragraph

Review in Angewandte Chemie (International ed. in English), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed.

  1. Enhanced anticancer efficacy ofMaterials today. Bio · 2026
    Article
  2. Induction and Stabilization of Peptide Alpha-Helices on Silica Nanoparticles.Angewandte Chemie (International ed. in English) · 2026
    Article
  3. Article
  4. MinimalRSC chemical biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. De novo discovery of a molecular glue-like macrocyclic peptide that induces MCL1 homodimerization.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Leila PeraroDepartment of Chemistry, Tufts University, Medford, Massachusetts, 02155, USA.
Joshua A KritzerDepartment of Chemistry, Tufts University, Medford, Massachusetts, 02155, USA.ORCID 0000-0003-2878-6781

Funding

Cell Penetration Profiling for BiotherapeuticsR01GM127585 · NIGMS · TUFTS UNIVERSITY MEDFORD · PI KRITZER, JOSHUA A · 2018 to 2022
$1.6M
High-Throughput Assays for Inhibitors of Understudied Bacterial ProteasesR01GM111042 · NIGMS · TUFTS UNIVERSITY MEDFORD · PI KRITZER, JOSHUA A · 2015 to 2017
$856k
NIGMS NIH HHS GM111042NIGMS NIH HHS GM127585NIGMS NIH HHS R01 GM127585
6 · The paper itself

Abstract

Biomolecules such as antibodies, proteins, and peptides are important tools for chemical biology and leads for drug development. They have been used to inhibit a variety of extracellular proteins, but accessing intracellular proteins has been much more challenging. In this review, we discuss diverse chemical approaches that have yielded cell-penetrant peptides and identify three distinct strategies: masking backbone amides, guanidinium group patterning, and amphipathic patterning. We summarize a growing number of large data sets, which are starting to reveal more specific design guidelines for each strategy. We also discuss advantages and disadvantages of current methods for quantifying cell penetration. Finally, we provide an overview of best-odds approaches for applying these new methods and design principles to optimize cytosolic penetration for a given bioactive peptide.

Indexed as

AmidesCell-Penetrating PeptidesGuanidineHumansMicroscopy, FluorescencePeptides, CyclicProtein Conformation, alpha-HelicalStatic ElectricitySurface PropertiesAmidesCell-Penetrating PeptidesGuanidinePeptides, Cycliccell-penetrating peptidescellular deliverycyclic peptidespeptide therapeutics

Identifiers

PMID29740917
PMCPMC7184558

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.